(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 11.22% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.95%.
Astrana Health's revenue in 2026 is $3,526,482,000.On average, 13 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,377,893,820, with the lowest ASTH revenue forecast at $215,900,352,500, and the highest ASTH revenue forecast at $239,134,016,240. On average, 13 Wall Street analysts forecast ASTH's revenue for 2027 to be $249,162,935,840, with the lowest ASTH revenue forecast at $230,553,718,360, and the highest ASTH revenue forecast at $268,162,166,860.
In 2028, ASTH is forecast to generate $270,000,802,120 in revenue, with the lowest revenue forecast at $255,626,017,360 and the highest revenue forecast at $285,712,776,160.